Expression Strategies

VectorsCell linesIntermediate

Transient transfection, stable cell lines, and viral transduction each occupy different positions on the speed–uniformity–cell type flexibility spectrum. Choosing the wrong approach can mean weeks of lost optimization time.

3
Delivery strategies
9
Decision attributes
24 h – months
Time-to-expression range
Transgene expression strategy — choosing your delivery and persistence model
Attribute Transient transfection Stable cell line Viral transduction
Expression persistence Days (2–7 d peak) Permanent (clonal selection) Long-term to permanent (vector-dependent)
Time to expression 24–72 h Weeks–months (selection + clonal expansion) Days–weeks
Screening throughput
Cell type flexibility High (most dividing cell lines) Moderate (selection marker required) High (incl. primary, non-dividing)
Expression uniformity Variable (mosaic, transient) Uniform (clonal) MOI-dependent
Protein yield
Genomic integration No Yes (random or targeted) Vector-dependent (LV: yes; AAV: typically no)
Biosafety overhead Minimal Minimal BSL-2 required for most vectors
Best for Rapid protein production, construct screening, transient knockdown/overexpression Stable reporter lines, drug screening platforms, long-term phenotypic studies Primary cells, in vivo studies, non-dividing cell engineering, CAR-T programs

MOI = multiplicity of infection · HTS = high-throughput screening. Selection marker choice (puromycin, blasticidin, G418) significantly affects stable line generation timeline.